Literature DB >> 24920569

The alteration of the C-terminal region of human frataxin distorts its structural dynamics and function.

Santiago E Faraj1, Ernesto A Roman, Martin Aran, Mariana Gallo, Javier Santos.   

Abstract

Friedreich's ataxia (FRDA) is linked to a deficiency of frataxin (FXN), a mitochondrial protein involved in iron-sulfur cluster synthesis. FXN is a small protein with an α/β fold followed by the C-terminal region (CTR) with a nonperiodic structure that packs against the protein core. In the present study, we explored the impact of the alteration of the CTR on the stability and dynamics of FXN. We analyzed several pathological and rationally designed CTR mutants using complementary spectroscopic and biophysical approaches. The pathological mutation L198R yields a global destabilization of the structure correlating with a significant and highly localized alteration of dynamics, mainly involving residues that are in contact with L198 in wild-type FXN. Variant FXN 90-195, which is closely related to the FRDA-associated mutant FXN 81-193, conserves a globular shape with a native-like structure. However, the truncation of the CTR results in an extreme alteration of global stability and protein dynamics over a vast range of timescales and encompassing regions far from the CTR, as shown by proton-water exchange rates and (15) N-relaxation measurements. Increased sensitivity to proteolysis, observed in vitro for both mutants, suggests a faster degradation rate in vivo, whereas the enhanced tendency to aggregate exhibited by the truncated variant may account for the loss of functional FXN, with both phenomena providing an explanation as to why the alteration of the CTR causes FRDA. These results contribute to understanding how stability and activity are linked to protein motions and they might be useful for the design of target-specific ligands to control local protein motions for stability enhancement.
© 2014 FEBS.

Entities:  

Keywords:  Friedreich's ataxia; NMR; molecular motions; protein folding; protein stability

Mesh:

Substances:

Year:  2014        PMID: 24920569     DOI: 10.1111/febs.12869

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  8 in total

Review 1.  Molecular Details of the Frataxin-Scaffold Interaction during Mitochondrial Fe-S Cluster Assembly.

Authors:  Courtney J Campbell; Ashley E Pall; Akshata R Naik; Lindsey N Thompson; Timothy L Stemmler
Journal:  Int J Mol Sci       Date:  2021-06-02       Impact factor: 5.923

2.  Human Frataxin Folds Via an Intermediate State. Role of the C-Terminal Region.

Authors:  Santiago E Faraj; Rodolfo M González-Lebrero; Ernesto A Roman; Javier Santos
Journal:  Sci Rep       Date:  2016-02-09       Impact factor: 4.379

Review 3.  Friedreich Ataxia: current status and future prospects.

Authors:  Katrin Bürk
Journal:  Cerebellum Ataxias       Date:  2017-04-07

4.  Biophysical characterisation of the recombinant human frataxin precursor.

Authors:  Ignacio Hugo Castro; Alejandro Ferrari; María Georgina Herrera; Martín Ezequiel Noguera; Lorenzo Maso; Monica Benini; Alessandra Rufini; Roberto Testi; Paola Costantini; Javier Santos
Journal:  FEBS Open Bio       Date:  2018-01-25       Impact factor: 2.693

5.  Global Implications of Local Unfolding Phenomena, Probed by Cysteine Reactivity in Human Frataxin.

Authors:  Santiago E Faraj; Martín E Noguera; José María Delfino; Javier Santos
Journal:  Sci Rep       Date:  2019-02-11       Impact factor: 4.379

6.  Partial structure, dampened mobility, and modest impact of a His tag in the SARS-CoV-2 Nsp2 C-terminal region.

Authors:  Miguel Mompeán; Miguel Á Treviño; Douglas V Laurents
Journal:  Eur Biophys J       Date:  2021-10-11       Impact factor: 1.733

Review 7.  Protein Mutations and Stability, a Link with Disease: The Case Study of Frataxin.

Authors:  Rita Puglisi
Journal:  Biomedicines       Date:  2022-02-11

8.  A Highly Conserved Iron-Sulfur Cluster Assembly Machinery between Humans and Amoeba Dictyostelium discoideum: The Characterization of Frataxin.

Authors:  Justo Olmos; María Florencia Pignataro; Ana Belén Benítez Dos Santos; Mauro Bringas; Sebastián Klinke; Laura Kamenetzky; Francisco Velazquez; Javier Santos
Journal:  Int J Mol Sci       Date:  2020-09-17       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.